1. |
Braunwald E. The war against heart failure: the Lancet lecture. Lancet, 2015, 385(9970): 812-824.
|
2. |
Moran AE, Forouzanfar MH, Roth GA, et al. The global burden of ischemic heart disease in 1990 and 2010: the global burden of disease 2010 study. Circulation, 2014, 129(14): 1493-501.
|
3. |
Gibbon JH Jr. Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med, 1954, 37(3): 171-185.
|
4. |
Bregman D, Cohen SR. Mechanical techniques of circulation support: a percutaneous intra-aortic balloon device. Artif Organs, 1983, 7(1): 38-48.
|
5. |
Kretzschmar D, Schulze PC, Ferrari MW. Hemodynamic Performance of a novel Right Ventricular Assist Device(PERKAT®). ASAIO J, 2017, 63(2): 123-127.
|
6. |
Ihdayhid AR, Chopra S, Rankin J, et al. Intra-aortic balloon pump: indications, efficacy, guidelines and future directions. Curr Opin Cardiol, 2014, 29(4): 285-292.
|
7. |
Thiele H, Ohman EM, Desch S, et al. Steffen desch. management of cardiogenic shock. Eur Heart J, 2015, 36(20): 1223-1230.
|
8. |
潘宏伟, 郭莹, 彭建强, 等. 主动脉内球囊反搏在急性心肌梗死并泵衰竭患者不同时机的应用. 中国动脉硬化杂志, 2014, 22(1): 65-68.
|
9. |
Hill JD, O'Brien TG, Murray JJ, et al. Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). Use of the Bramson membrane lung. N Engl J Med, 1972, 286(12): 629-634.
|
10. |
Schmidt M, Tachon G, Devilliers C, et al. Blood oxygenation and decarboxylation determinants during venovenous ECMO for respiratory failure in adults. Intensive Care Med, 2013, 39(5): 838-846.
|
11. |
Makdisi G, Wang IW. Extra corporeal membrane oxygenation(ECMO) review of a lifesaving technology. Thorac Dis, 2015, 7(7): E166-E176.
|
12. |
Deakey ME. The odyssey of the artificial heart. Artificial Organs, 2000, 24(6): 405-411.
|
13. |
Colombo D, Ammirati E. Cyclosporine in transplantation-a history of converging timelines. J Biol Regul Homeost Agents, 2011, 25(4): 493-504.
|
14. |
Hunt SA, Haddad F. The changing face of heart transplantation. J Am Coll Cardiol, 2008, 52(8): 587-598.
|
15. |
Schumer EM, Black MC, Monreal G, et al. Left ventricular assist devices: current controversies and future directions. Eur Heart J, 2016, 37(46): 3434-3439.
|
16. |
Portner PM, Oyer PE, Pennington DG, et al. Implantable electrical left ventricular assist system: bridge to transplantation and the future. Ann Thorac Surg, 1989, 47(1): 142-150.
|
17. |
Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med, 2001, 345(20): 1435-1443.
|
18. |
Prinzing A, Herold U, Berkefeld A, et al. Left ventricular assist devices-current state and perspectives. J Thorac Dis, 2016, 8(8): E660-E666.
|
19. |
Cook JA, Shah KB, Tang DG, et al. The total artificial heart. J Thorac Dis, 2015, 7(12): 2172-2180.
|
20. |
Silva G, Melica B, Pires de Morais G, et al. Percutaneous implantation of a ventricular partitioning device for treatment of ischemic heart failure: initial experience of a center. Rev Port Cardiol, 2012, 31(12): 795-801.
|
21. |
Mazzaferri EL Jr, Gradinac S, Sagic D, et al. Percutaneous left ventricular partitioning in patients with chronic heart failure and a prior anterior myocardial infarction: Results of the PercutAneous Ventricular RestorAtion in Chronic Heart failure. Patients Trial. Am Heart J, 2012, 163: 812-820.
|
22. |
马为, 洪涛, 李建平, 等. 经皮心室重建术—附两例病例报告. 中国介入心脏病学杂志, 2013, 21(5): 274-277.
|
23. |
Hochleitner M, Hörtnagl H, Gschnitzer F, et al. Long-term efficacy of physiologic dual-chamber pacing in the treatment of end-stage idiopathic dilated cardiomyopathy. Am J Cardiol, 1992, 70(15): 1320-1325.
|
24. |
Yu CM, Fung WH, Sanderson JE, et al. Understanding nonresponders of cardiac resynchronization therapy-current and future perspectives. J Cardiovasc Electrophysiol, 2005, 16(10): 1117-1124.
|
25. |
Achilli A, Peraldo C, Puglisi A, et al. Prediction of response to cardiac resynchronization therapy: the selection of candidates for CRT(SCART) study. Pacing Clin Electrophysiol, 2006, 29(Suppl 2): S11-S19.
|
26. |
Epstein AE, DiMarco JP, Yancy CW, et al. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol, 2008, 51(21): e1-62.
|
27. |
Menard C, Hagege AA, Agbulut O, et al. Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet, 2005, 366(9490): 1005-1012.
|
28. |
Xu C, Police S, Rao N, et al. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res, 2002, 91(6): 501-508.
|
29. |
Brockbank KG, Piersma AH, Voerman JS, et al. Stromal cells (CFU-F) in normal and genetically anemic mouse strains. Acta Haematol, 1985, 74(2): 75-80.
|
30. |
Owen M, Friedenstein AJ. Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp, 1988, 136: 42-60.
|
31. |
Chi C, Wang F, Tian G, et al. Adipose-derived stem cells from both visceral and subcutaneous fat deposits significantly improve contractile function of infarcted rat hearts. Cell Transplant, 2015, 24(11): 2337-2351.
|
32. |
Mohsin S, Siddiqi S, Sussman MA, et al. Empowering adult stem cells for myocardial regeneration. Circ Res, 2011, 109(12): 1415-1428.
|
33. |
Menasche P, Hagege AA, Vilquin JT, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol, 2003, 41(7): 1078-1083.
|
34. |
Murry CE, Reinecke H, Pabon LM, et al. Regeneration gaps: observations on stem cells and cardiac repair. J Am Coll Cardiol, 2006, 47(9): 1777-1785.
|
35. |
Javazon EH, Beggs KJ, Flake AW. Mesenchymal stem cells: paradoxes of passaging. Exp Hematol, 2004, 32(5): 414-425.
|
36. |
Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factor. Cell, 2006, 126(4): 663-676.
|
37. |
Zhang J, Wilson GF, Soerens AG, et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res, 2009, 104(4): e30-e41.
|
38. |
Minami H, Tashiro K, Kawabata K, et al. Generation of brain microvascular endothelial-like cells from human induced pluripotent stem cells by co-culture with C6 glioma cells. PLoS One, 2015, 10(6): e0128890.
|
39. |
Yoo CH, Na HJ, Lee DS, et al. Endothelial progenitor cells from human dental pulp-derived iPS cells as a therapeutic target for ischemic vascular diseases. Biomaterials, 2013, 34(33): 8149-8160.
|
40. |
Matsuura K, Wada M, Okano T, et al. Creation of human cardiac cell sheets using pluripotent stem cells. Biochem Biophys Res Commun, 2012, 425(2): 321-327.
|
41. |
Talkhabi M, Aghdami N, Baharvand H. Human cardiomyocyte generation from pluripotent stem cells: A state-of-art. Life Sci, 2016, 145: 98-113.
|
42. |
Burridge PW, Elena Matsa E, Wu JC, et al. Chemically defined generation of human cardiomyocytes. Nat Methods, 2014, 11(8): 855-860.
|
43. |
Tran TH, Wang X, Burcin M, et al. Wnt3a-induced mesoderm formation and cardiomyogenesis in human embryonic stem cells. Stem Cells, 2009, 27(8): 1869-1878.
|
44. |
Kattman SJ, Witty AD, Keller G, et al. Stage-specific optimization of activin/nodal and bmp signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell, 2011, 8(2): 228-240.
|
45. |
Zhang J, Klos M, Kamp TJ, et al. Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method. Circ Res, 2012, 111(9): 1125-1136.
|
46. |
Sirabella D, Cimetta E, Vunjak-Novakovic G. " The state of the heart”: Recent advances in engineering human cardiac tissue from pluripotent stem cells. Exp Biol Med (Maywood), 2015, 240(8): 1008-1018.
|
47. |
Amano Y, Nishiguchi A, Sawa Y, et al. Development of vascularized iPSC derived 3D-cardiomyocyte tissues by filtration Layer-by-Layer technique and their application for pharmaceutical assays. Acta Biomater, 2016, 33: 110-121.
|
48. |
Yamanaka S. A fresh look at iPS cells. Cell, 2009, 137(1): 13-17.
|
49. |
Beltrami AP, Barlucchi L, Anversa P, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell, 114(6): 763-776.
|
50. |
Bolli R, Chugh AR, Anversa P, et al. Effect of cardiac stem cells in patients with ischemic cardiomyopathy: initial results of the SCIPIO trial. Lancet, 2011, 378(9806): 1847-1857.
|
51. |
Zaruba MM, Soonpaa M, Reuter S, et al. Cardiomyogenic potential of C-kit(+)-expressing cells derived from neonatal and adult mouse hearts. Circulation, 2010, 121(18): 1992-2000.
|
52. |
Lalit PA, Salick MR, Nelson DO, et al. Lineage reprogramming of fibroblasts into proliferative induced cardiac progenitor cells by defined factors. Cell Stem Cell, 2016, 18(3): 354-367.
|
53. |
Olivetti G, Capasso JM, Anversa P, et al. Side-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats. Circ Res, 1990, 67(1): 23-34.
|
54. |
Caulfield JB, Leinbach R, Gold H. The relationship of myocardial infarct size and prognosis. Circulation, 1976, 53(3 Suppl): I141-I144.
|